Showing 1821-1830 of 2757 results for "".
- Dr. Paul M. Friedman Named New ASLMS Presidenthttps://modernaesthetics.com/news/dr-paul-m-friedman-named-new-aslms-president/2473244/Paul M. Friedman, MD is the new President of the American Society for Laser Medicine and Surgery (ASLMS). Dr. Friedman, board-certified by the American Board of Dermatology, is the director of Dermatology & Laser Surgery Center of Houston
- Colorescience Finishing Touch Protocol Boosts Patient Satisfaction after Microneedling RFhttps://modernaesthetics.com/news/colorescience-finishing-touch-protocol-boosts-patient-satisfaction-after-microneedling-rf/2473243/Colorescience’s Finishing Touch post-treatment skincare protocol improves patient confidence, comfort, satisfaction, and increases the likelihood of a repeat radiofrequency microneedling procedure, according to research in The Journal of Clinical and Aesthetic Dermatology
- Crown Laboratories to Acquire Eclipse Aesthetics Assetshttps://modernaesthetics.com/news/crown-laboratories-to-acquire-eclipse-aesthetics-assets/2473242/Crown Laboratories will acquire the global aesthetics-focused assets of Eclipse. The acquisition expands Crown's aesthetics' product portfolio and enhances Crown's overall value proposition as a global leader in science-based aesthetic skincare solutions.
- Rion Aesthetics Initiates Series Ahttps://modernaesthetics.com/news/rion-aesthetics-initiates-series-a/2473241/With the initiation of Series A funding, Rion Aesthetics presents a unique investment opportunity for aesthetic providers. Rion plans on closing the Series A in the second quarter of 2022. Rion, a regenerati
- Merz Aesthetics Partners with North Carolina Courage, Reigning NWSL Challenge Cup Championshttps://modernaesthetics.com/news/merz-aesthetics-partners-with-north-carolina-courage-reigning-nwsl-challenge-cup-champions/2473240/In a new partnership with the North Carolina Courage, reigning NWSL Challenge Cup Champions and two-time champions of the National Women’s Soccer League (NWSL), Merz Aesthetics aims to promote confidence, character, and sportsmanship. The partnership, kicking off Sunday, includes
- Evolus Celebrates Third Anniversary of the Launch of Jeuveauhttps://modernaesthetics.com/news/evolus-celebrates-third-anniversary-of-the-launch-of-jeuveau/2473239/Evolus, Inc. is celebrating the three-year anniversary of the launch of its flagship neurotoxin product, Jeuveau (prabotulinumtoxinA-xvfs), the first neurotoxin dedicated exclusively to aesthetics. Jeuveau is used for the temporary improvement in the appearance of moderate to severe ve
- Cynosure Receives $60 Million Follow-on Investment from Clayton, Dubilier & Ricehttps://modernaesthetics.com/news/cynosure-recieves-60-million-follow-on-investment-from-clayton-dubilier-rice/2473237/Cynosure, LLC, received $60 million from lead investor Clayton, Dubilier & Rice. The new capital supports the company's plans to continue investing ahead of strong growth to bring innovation to the market and provide comprehensive treatment solutions to its cust
- ISHRS Survey: Surgical Advances; Improvements in Efficiency Driving Need for Fewer Hair Transplant Treatmentshttps://modernaesthetics.com/news/ishrs-survey-surgical-advances-improvements-in-efficiency-driving-need-for-fewer-hair-transplant-treatments/2473235/According to results of a new member survey conducted by the International Society of Hair Restoration Surgery (ISHRS), 68 percent of members reported performing an average of one procedure per patient in 2021 to achieve the desired hair restoration result. This represents a significant improveme
- Meet Avéli, Cellulite's Latest Foehttps://modernaesthetics.com/news/meet-aveli-cellulites-latest-foe/2473234/Revelle Aesthetics, In
- CellFX from Pulse Biosciences Shows Durable Effects for Sebaceous Hyperplasia: ASLMS Presentationhttps://modernaesthetics.com/news/cellfx-from-pulse-biosciences-shows-durable-effects-for-sebaceous-hyperplasia-aslms-presentation/2473233/The CellFX® system from Pulse Biosciences, Inc. demonstrates durable efficacy for the clearance of Sebaceous Hyperplasia lesions, according to data presented at the 2022